Illuneo: a non-invasive, continuous blood glucose bedside measurement for preterm infants at the neonatal intensive care unit

• Research unit: INNOSUISSE
• Project number: 25598.2 PFNM-NM

Short description (German)

Illuneo: a non-invasive, continuous blood glucose bedside measurement for preterm infants at the neonatal intensive care unit

Short description (English)

Illuneo: a non-invasive, continuous blood glucose bedside measurement for preterm infants at the neonatal intensive care unit

Abstract (German)

The aim is to prevent impaired brain development in extreme and very preterm neonates in addition to reducing pain, infection risks, and to lowering costs for hospitals via continuous, non-invasive, transdermal, auto-calibrating glucose monitoring with passive diffusion. We developed, patented and tested in vitro a novel measurement principle with two parallel measurements for calibrating skin resistance. We now need to prove our new principle in a clinical pilot trial.

Abstract (English)

The aim is to prevent impaired brain development in extreme and very preterm neonates in addition to reducing pain, infection risks, and to lowering costs for hospitals via continuous, non-invasive, transdermal, auto-calibrating glucose monitoring with passive diffusion. We developed, patented and tested in vitro a novel measurement principle with two parallel measurements for calibrating skin resistance. We now need to prove our new principle in a clinical pilot trial.